COVID-19: South African firm makes Africa’s first mRNA vaccine
A South African biotech firm, Afrigen, said Thursday it has produced the first mRNA COVID vaccine made on the continent and that it will be ready for clinical trials in November. Cape Town-based Afrigen Biologics and Vaccines is leading the pilot project, backed by the World Health Organization and the COVAX initiative, to tweak Moderna’s…